Israel’s BioLight Life Sciences has completed a successful U.S. clinical study designed to assess the effectiveness of its TeaRx multi-assay test in evaluating tears’ components of patients suffering from dry eye syndrome (DES) as well as those of healthy subjects.
http://www.bio-light.co.il/blog/positive-second-clinical-study-results-for-its-tearx/